This recombinant monoclonal antibody is a research-grade biosimilar to CNTO-5, designed for research targeting Toll-like receptor 3 (TLR3). TLR3 is a pattern recognition receptor primarily localized in endosomes that detects double-stranded RNA, a molecular signature of viral infection. Upon activation, TLR3 triggers innate immune responses through the TRIF-dependent signaling pathway, leading to production of type I interferons and pro-inflammatory cytokines. This receptor plays critical roles in antiviral immunity, and its dysregulation has been implicated in various pathological conditions including viral infections, autoimmune diseases, cancer, and inflammatory disorders.
CNTO-5 is a well-characterized neutralizing antibody that has been employed in studies investigating TLR3-mediated immune responses and inflammatory pathways. This biosimilar provides researchers with a reliable tool for exploring TLR3 biology, examining its role in innate immunity, studying viral recognition mechanisms, and investigating therapeutic interventions in TLR3-associated diseases. The antibody is valuable for experiments aimed at understanding how TLR3 signaling contributes to disease pathogenesis and for evaluating potential immunomodulatory strategies.
Email: support@cusabio.com
Distributors Worldwide